Drug recall D-607-2013
Product
Norpace CR (disopyramide phosphate) extended-release capsules USP,150 mg, packaged in a) 100-count bottles (NDC 0025-2742-31), and b) 500-count bottles (NDC 0025-2742-51), Rx only, Distributed by G.D. Searle LLC, Division of Pfizer Inc, NY, NY 10017.
Reason for recall
Failed Dissolution Specification
Lots and codes
Lot #: a) C120138, Exp 07/13; b) C120137, Exp 07/13
Recall details
- Recalling firm
- Pfizer Inc, Peapack, NJ
- Quantity
- 5,410 botlles
- Distribution
- Nationwide and Puerto Rico
- Type
- Voluntary: Firm initiated
- Recall initiated
- May 31, 2013
- Terminated
- June 5, 2015
Related products
- Norpace – drug information
- NDC 0025-2762 Norpace · Disopyramide Phosphate 150 mg/1 · Pfizer Laboratories Div Pfizer Inc
- NDC 0025-2752 Norpace · Disopyramide Phosphate 100 mg/1 · Pfizer Laboratories Div Pfizer Inc